research use only
Cat.No.S2554
| Related Targets | VEGFR JAK PDGFR FGFR Src HIF FLT FLT3 HER2 Bcr-Abl |
|---|---|
| Other EGFR Inhibitors | Lazertinib (YH25448) Icotinib Hydrochloride Sunvozertinib AG-490 AG-1478 Canertinib (CI-1033) WZ4002 Rociletinib (CO-1686) Poziotinib (NOV120101, HM781-36B) Genistein |
| Molecular Weight | 178.14 | Formula | C9H6O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 486-35-1 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1=CC(=C(C2=C1C=CC(=O)O2)O)O | ||
|
In vitro |
DMSO
: 36 mg/mL
(202.08 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
EGFR
7.67 μM
PKA
9.33 μM
PKC
25.01 μM
|
|---|---|
| In vitro |
Daphnetin strongly inhibits not only EGF receptor-catalysed tyrosine phosphorylation of exogenous substrate but also PKA and PKC activities. This compound inhibits MCF-7 oestrogen-responsive human carcinoma cell line at 24-hour exposure with IC50 of 73 μM. It reduces the level of cyclin D1 even at 50 μM. This chemical protects the cortical neurones against dexamethasone-induced reduction of cell viability in a dose-dependent manner. It inhibits the activities of endogenous or recombinant TaPRK in a specific and dose-dependent manner. This compound causes a 50% inhibition (IC50) of 3H-hypoxanthine incorporation by Plasmodium falciparum at concentrations between 25 μM and 40 μM. It inhibits the mitogenic signalling of ERK1/ERK2.
|
| Kinase Assay |
Assay of protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) activities.
|
|
PKC and PKA activities are detected. Briefly, 5 mL of PKC or PKA is mixed with 5 mL of lipid preparation containing 100 mM phorbol 12-myristate 13-acetate, 2.8 mg/mL phosphatidyl serine, and Triton X-100 mixed micelles for PKC assay or 5 mL of 40 mM cAMP in 50 mM Tris-HCl, pH 7.5, for PKA assay, and 5 mL of daphnetin. The reaction is started by adding 10 mL of PKC substrate solution containing 250 mM acetylated myelin basic protein, 100 mM ATP, 5 mM CaCl2, 10 mM MgCl2, 20 mM Tris-HCl, pH 7.5, or 10 mL of PKA substrate solution containing 200 mM Kemptide, 400 mM ATP, 40 mM MgCl2, 1 mg/mL BSA, 50 mM Tris-HCl, pH 7.5, and 20-25 mCi/mL [g-32P] ATP. After incubation at 25 °C for 5 minutes, 20 mL of each mixture is spotted on a piece of phosphocellulose disc which is immediately put into 1% H3PO4. After free [g-32P] ATP on the discs is removed, the peptide-incorporated 32P on the discs is counted in a scintillation counter.
|
|
| In vivo |
Daphnetin at 140 mg/kg significantly decreases uterine weights by 39.5%. Two and 8 mg/kg administration of this compound could improve the performance of stress mice in Morris water maze tests and forced swimming tests. This chemical significantly prolongs survival of P. yoelli-infected mice.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.